Budget Impact Analysis Of Biosimilar Infliximab For The Treatment Of Crohn's Disease In Six Central Eastern European Countries
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.805
https://www.valueinhealthjournal.com/article/S1098-3015(14)02735-1/fulltext
Title :
Budget Impact Analysis Of Biosimilar Infliximab For The Treatment Of Crohn's Disease In Six Central Eastern European Countries
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02735-1&doi=10.1016/j.jval.2014.08.805
First page :
A364
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
230